Skip to main content
SpringerLink
Log in

Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al

  • Commentary
  • Published:
Quality of Life Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Maratia, S., Cedillo, S., & Rejas, J. (2016). Assessing health-related quality of life in patients with breast cancer: A systematic and standardized comparison of available instruments using the EMPRO tool. Quality of Life Research, 25(10), 2467–2480. doi:10.1007/s11136-016-1284-8.

    Article  PubMed  Google Scholar 

  2. Bernhard, J., Hürny, C., Coates, A. S., Peterson, H. F., Castiglione-Gertsch, M., Gelber, R. D., et al. (1997). Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach. Annals of Oncology, 8(9), 825–835.

    Article  CAS  PubMed  Google Scholar 

  3. Valderas, J. M., Ferrer, M., Mendivil, J., Garin, O., Rajmil, L., Herdman, M., et al. (2008). Development of EMPRO: A tool for the standardized assessment of patient-reported outcome measures. Value Health, 11(4), 700–708. doi:10.1111/j.1524-4733.2007.00309.x.

    Article  PubMed  Google Scholar 

  4. Bernhard, J., Peterson, H. F., Coates, A. S., Gusset, H., Isley, M., Hinkle, R., et al. (1998). Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: Practical issues and factors associated with missing data. Statistics in Medicine, 17(5–7), 587–601.

    Article  CAS  PubMed  Google Scholar 

  5. Butow, P., Coates, A., Dunn, S., Bernhard, J., & Hurny, C. (1991). On the receiving end. IV: Validation of quality of life indicators. Annals of Oncology, 2(8), 597–603.

    Article  CAS  PubMed  Google Scholar 

  6. Bernhard, J., Sullivan, M., Hurny, C., Coates, A. S., & Rudenstam, C. M. (2001). Clinical relevance of single item quality of life indicators in cancer clinical trials. British Journal of Cancer, 84(9), 1156–1165.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hurny, C., Bernhard, J., Coates, A., Peterson, H. F., Castiglione-Gertsch, M., Gelber, R. D., et al. (1996). Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Medical Care, 34(3), 234–248.

    Article  CAS  PubMed  Google Scholar 

  8. Hurny, C., Bernhard, J., Bacchi, M., van Wegberg, B., Tomamichel, M., Spek, U., et al. (1993). The Perceived Adjustment to Chronic Illness Scale (PACIS): A global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG). Supportive Care in Cancer, 1(4), 200–208.

    Article  CAS  PubMed  Google Scholar 

  9. Hürny, C., van Wegberg, B., Bacchi, M., Bernhard, J., Thürlimann, B., Ral, O., et al. (1998). Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for cancer clinical trials. British Journal of Cancer, 77, 985–991.

    Article  PubMed  Google Scholar 

  10. Michels, F. A. S., Latorre, R. D. O., & Maciel, M. S. (2010). Validation, reliability, and comprehension of the IBCSG quality of life questionnaire specifi to Breast Cancer. Applied Cancer Research, 30(4), 348–352.

    Google Scholar 

  11. Hurny, C., Bernhard, J., Gelber, R. D., Coates, A., Castiglione, M., Isley, M., et al. (1992). Quality of life measures for patients receiving adjuvant therapy for breast cancer: An international trial. The International Breast Cancer Study Group. European Journal of Cancer, 28(1), 118–124.

    Article  CAS  PubMed  Google Scholar 

  12. Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value Health, 8(2), 94–104. doi:10.1111/j.1524-4733.2005.04054.x.

    Article  PubMed  Google Scholar 

  13. Coates, A., Abraham, S., Kaye, S. B., Sowerbutts, T., Frewin, C., Fox, R. M., et al. (1983). On the receiving end–patient perception of the side-effects of cancer chemotherapy. European Journal of Cancer and Clinical Oncology, 19(2), 203–208.

    Article  CAS  PubMed  Google Scholar 

  14. Coates, A., Glasziou, P., & McNeil, D. (1990). On the receiving end–III. Measurement of quality of life during cancer chemotherapy. Annals of Oncology, 1(3), 213–217.

    Article  CAS  PubMed  Google Scholar 

  15. International Breast Cancer Study G, Rudenstam, C. M., Zahrieh, D., Forbes, J. F., Crivellari, D., Holmberg, S. B., et al. (2006). Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: First results of International Breast Cancer Study Group Trial 10–93. Journal of Clinical Oncology, 24(3), 337–344. doi:10.1200/JCO.2005.01.5784.

    Article  Google Scholar 

  16. Hurny, C., Bernhard, J., Coates, A. S., Castiglione-Gertsch, M., Peterson, H. F., Gelber, R. D., et al. (1996). Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group. Lancet, 347(9011), 1279–1284.

    CAS  Google Scholar 

  17. Bernhard, J., Zahrieh, D., Zhang, J. J., Martinelli, G., Basser, R., Hurny, C., et al. (2008). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British Journal of Cancer, 98(1), 25–33. doi:10.1038/sj.bjc.6604092.

    Article  CAS  PubMed  Google Scholar 

  18. Bernhard, J., Zahrieh, D., Castiglione-Gertsch, M., Hurny, C., Gelber, R. D., Forbes, J. F., et al. (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: The impact on amenorrhea, hot flashes, and quality of life in premenopausal patients—the International Breast Cancer Study Group Trial VIII. Journal of Clinical Oncology, 25(3), 263–270.

    Article  CAS  PubMed  Google Scholar 

  19. Bernhard, J., Luo, W., Ribi, K., Colleoni, M., Burstein, H. J., Tondini, C., et al. (2015). Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): A combined analysis of two phase 3 randomised trials. Lancet Oncology, 16(7), 848–858. doi:10.1016/S1470-2045(15)00049-2.

    Article  CAS  PubMed  Google Scholar 

  20. Ribi, K., Luo, W., Bernhard, J., Francis, P. A., Burstein, H. J., Bellet, M., et al. (2016). Adjuvant tamoxifen plus ovarian function suppression versus tamoxifen-alone in premenopausal women with early breast cancer: patient-reported outcome in the SOFT trial. Journal of Clinical Oncology, 34(14), 1601–1610.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Bernhard, J., Castiglione-Gertsch, M., Schmitz, S. F., Thurlimann, B., Cavalli, F., Morant, R., et al. (1999). Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonal treatment. Swiss group for clinical cancer research (SAKK). European Journal of Cancer, 35(6), 913–920.

    Article  CAS  PubMed  Google Scholar 

  22. Bernhard, J., Thurlimann, B., Schmitz, S. F., Castiglione-Gertsch, M., Cavalli, F., Morant, R., et al. (1999). Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? Journal of Clinical Oncology, 17(6), 1672–1679.

    Article  CAS  PubMed  Google Scholar 

  23. Lee, C. K., Stockler, M. R., Coates, A. S., Gebski, V., Lord, S. J., & Simes, R. J. (2010). Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British Journal of Cancer, 102(9), 1341–1347.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Coates, A., Gebski, V., Signorini, D., Murray, P., McNeil, D., Byrne, M., et al. (1992). Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group. Journal of Clinical Oncology, 10(12), 1833–1838.

    Article  CAS  PubMed  Google Scholar 

  25. Coates, A. S., Hürny, C., Peterson, H. F., Bernhard, J., Castiglione-Gertsch, M., Gelber, R. D., et al. (2000). Quality-of-life scores predict outcome in metastatic but not early breast cancer. Journal of Clinical Oncology, 18(22), 3768–3774.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

There was no funding for this commentary.

Author information

Authors and Affiliations

  1. International Breast Cancer Study Group (IBCSG) Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland

    Karin Ribi

  2. International Breast Cancer Study Group and University of Sydney, Sydney, Australia

    Alan Coates

  3. International Breast Cancer Study Group, Data Management Center, Amherst, NY, USA

    Lynette Blacher

  4. International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA

    Meredith M. Regan

  5. International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, Harvard T.H. Chan School of Public Health, Frontier Science and Technology Research Foundation, Boston, MA, USA

    Richard D. Gelber

  6. International Breast Cancer Study Group Coordinating Center and Bern University Hospital, Inselspital, Bern, Switzerland

    Jürg Bernhard

Authors
  1. Karin Ribi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alan Coates
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lynette Blacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Meredith M. Regan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Richard D. Gelber
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jürg Bernhard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin Ribi.

Ethics declarations

Conflict of interest

All authors declare no conflict of interest.

Ethical approval

In all studies referring to the IBCSG QoL Core Form cited in this commentary, procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in any of the studies referring to the IBCSG QoL Core Form cited in this commentary.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ribi, K., Coates, A., Blacher, L. et al. Assessing health-related quality of life in patients with breast cancer: a reply to Maratia et al. Qual Life Res 27, 149–152 (2018). https://doi.org/10.1007/s11136-017-1695-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-017-1695-1

Keywords

Search

Navigation